UroGen Pharma Ltd. drawdown: 48.1% below the all-time high (price)
UroGen Pharma Ltd. is 48.1% below its all-time high, set May 18, 2018 (as of market close, Oct 27, 2026), measured on price alone — dividends are not included, the convention headlines and crash histories use. The chart shows every day as a percentage of the highest level reached up to that point: 100% means a fresh record, everything below is a drawdown.
- Below all-time high
- −48.1%
- 51.9% of ATH
- All-time high
- $65.33
- May 18, 2018
- Time below the high
- 8.4 yrs
- since May 18, 2018
- Worst-ever drawdown
- −94.0%
- May 27, 2025
- Longest underwater
- 8.4 yrs
- between all-time highs
- Today's level first reached
- Nov 3, 2017
- 9.0 yrs ago
- Last time this deep
- never before
- no prior −48.1% episode
% of all-time high since 2017: price#
The classic underwater chart (drawdown curve), drawn as % of the all-time high — 100% is a fresh record, everything below it is time spent underwater. Basis and range are in the URL, so a particular view is a link.
The deepest drawdowns on record#
Every decline of 15% or more from an all-time high (price basis), deepest first.
| Peak | Trough | Depth | Peak → trough | Recovered by | Underwater |
|---|---|---|---|---|---|
| May 18, 2018 | May 27, 2025 | −94.0% | 7.0 yrs | not yet | 8.4 yrs+ |
| May 30, 2017 | Jun 15, 2017 | −20.1% | 16 days | Jun 26, 2017 | 27 days |
| Jan 25, 2018 | Feb 5, 2018 | −18.5% | 11 days | Mar 5, 2018 | 39 days |
| Sep 14, 2017 | Oct 20, 2017 | −16.6% | 36 days | Nov 2, 2017 | 49 days |
| Mar 14, 2018 | Apr 2, 2018 | −16.0% | 19 days | Apr 3, 2018 | 20 days |
Price basis (no dividends) — the convention crash histories use. With dividends reinvested, recoveries arrive years earlier; switch the basis on the chart above to see it.
Drawdown vs what came next#
One dot per month since 2017: how far UroGen Pharma Ltd. stood below its all-time high, and the total return over the following 1, 5 and 10 years.
Read this with survivorship bias in mind: a single asset's history is one surviving sample, so past recoveries here say little about the odds ahead. Monthly windows also overlap heavily (they are not independent samples). Not investment advice.
FAQ#
- How far is UroGen Pharma Ltd. from its all-time high?
- UroGen Pharma Ltd. is currently 48.1% below its all-time high, set May 18, 2018 (as of market close, Oct 27, 2026). Prices only, the convention headlines use; with dividends reinvested the gap is usually smaller.
- What was the biggest UroGen Pharma Ltd. drawdown ever?
- The deepest decline on record in our data (since 2017) took UroGen Pharma Ltd. 94.0% below its prior high, bottoming May 27, 2025. The table on this page lists every major episode with its peak, trough and recovery date.
Methodology & related#
Daily data since -1 from URGN; no free deep history exists for UroGen Pharma Ltd. — for a 150-year drawdown record see the S&P 500 drawdown page. The price basis excludes dividends; the total-return basis reinvests them; the real basis additionally deflates by CPI. See also returns by year. Past performance does not predict future returns; not investment advice.